Thomas Woiwode - Jun 11, 2021 Form 4 Insider Report for Aligos Therapeutics, Inc. (ALGS)

Role: Director
Signature: /s/ Robin L. Praeger, Attorney-in-fact for Thomas Woiwode
Stock symbol: ALGS
Transactions as of: Jun 11, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/15/2021, 04:43 PM
Previous filing: May 28, 2021
Next filing: Jun 17, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALGS	Common Stock	Other	$0	-486K	-25%	$0.00	1.46M	Jun 11, 2021	See Footnote	F1, F2
transaction	ALGS	Common Stock	Other	$0	+9.72K		$0.00	9.72K	Jun 11, 2021	See Footnote	F3, F4
transaction	ALGS	Common Stock	Other	$0	-9.72K	-100%	$0.00^*	0	Jun 11, 2021	See Footnote	F4, F5
transaction	ALGS	Common Stock	Other	$0	+8.38K		$0.00	8.38K	Jun 11, 2021	See Footnote	F6, F7
transaction	ALGS	Common Stock	Other	$0	-8.38K	-100%	$0.00^*	0	Jun 11, 2021	See Footnote	F7, F8
transaction	ALGS	Common Stock	Other	$0	+2.23K	+100%	$0.00	4.45K	Jun 11, 2021	Direct	F9
holding	ALGS	Common Stock						862K	Jun 11, 2021	See Footnote	F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. ("VVC VI") to its partners pursuant to a Rule 10b5-1 trading plan.
F2	Shares held by VVC VI. Versant Ventures VI GP, L.P. ("VV VI GP") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC ("VV VI GP-GP") is the general partner of VV VI GP. The Reporting Person is a managing member of VV VI GP-GP and may be deemed to share voting and dispositive power over the shares held by VVC VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.
F3	Represents a change in the form of ownership of VV VI GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by VVC VI.
F4	Shares held by VV VI GP. VV VI GP-GP is the general partner of VV VI GP. The Reporting Person is a managing member of VV VI GP-GP and may be deemed to share voting and dispositive power over the shares held by VV VI GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
F5	Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV VI GP, to its partners.
F6	Represents a change in the form of ownership of VV VI GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by VV VI GP.
F7	Shares held by VV VI GP-GP. The Reporting Person is a managing member of VV VI GP-GP and may be deemed to share voting and dispositive power over the shares held VV VI GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.
F8	Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV VI GP-GP, to its members.
F9	Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by VV VI GP-GP.
F10	Shares held by Versant Vantage I, L.P. ("VV I"). Versant Vantage I GP, L.P. ("VV I GP") is the general partner of VV I, and Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the general partner of VV I GP. The Reporting Person is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.